Sodium ferric gluconate complex - AbbVie
Alternative Names: FerrlecitLatest Information Update: 02 Oct 2021
At a glance
- Originator Watson Pharmaceuticals
- Developer AbbVie
- Class Antianaemics; Ferric compounds
- Mechanism of Action Iron replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Iron deficiency anaemia